UPM Pharmaceuticals is a contract development and manufacturing organization (CDMO) with a rich pedigree in late-stage commercial manufacturing of semi-solid and oral solid dose.
Operating out of a 475,000-square-foot, large-scale cGMP and FDA-guided manufacturing facility in Bristol, Tennessee, UPM combines the robust track record of a large pharmaceutical supplier with the agility of an independent, family-owned US-based CDMO. For our customers, this translates to exceptional quality and reliability — and a level of personalized service not often seen in a large pharma company in the US.
Beyond our expertise and technology, UPM is a contract manufacturing organization that has a passion for propelling our customers’ journeys to market, even when the journey doesn’t begin with us. As a large-scale CDMO, technology transfer and scale-up are our specialties; we welcome the opportunity to sit down with you to create a pharma solution by understanding the evolution of your project, your commercial goals, and how we can work together to get your product across the finish line.
Safe, Compliant Handling of DEA-Controlled Substances
Whether your product is oral-solid or semi-solid dose, establishing the appropriate analytical framework and formulation design is vital to ensuring optimal production at clinical and commercial scale. UPM’s R&D and formulation experts have advanced several complex compounds from concept to commercialization, applying multidisciplinary expertise to develop the best processing conditions and formulation solutions for each unique product.